Antibiotic resistance is often framed as a hospital problem, but a growing body of evidence shows that the environment plays ...

Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...

Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...

Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

Market opportunities include leveraging advancements in AI and machine learning to enhance microbiome data analysis, ...

Illumina Inc. presented at the J.P. Morgan 2026 Healthcare Conference on Jan. 13 and introduced what it said is the world's largest genome-wide genetic perturbation dataset, being built to accelerate ...